Windmill Hill Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Windmill Hill Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-163,768	Closed	-$3.97M	–	27
2025 Q3	$3.97M	Hold	163,768	–	–	1.04%	8
2025 Q2	$2.15M	Buy	163,768 +45,855	+39%	+$581K	0.59%	12
2025 Q1	$1.7M	Buy	+117,913	New	+$1.93M	0.52%	14

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Windmill Hill Asset Management's CNTA Position: Q4 2025 in Review

Windmill Hill Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 163,768 shares — an estimated $3.97M sold.

Windmill Hill Asset Management first reported a position in CNTA in Q1 2025 and held it in 3 quarters. The position peaked at $3.97M in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

Windmill Hill Asset Management reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Windmill Hill Asset Management sold 163,768 Centessa Pharmaceuticals shares in Q4 2025, an estimated $3.97M.
Windmill Hill Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Windmill Hill Asset Management's Centessa Pharmaceuticals position peaked at $3.97M in Q3 2025.
146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Windmill Hill Asset Management's 13F filing for Q4 2025, filed 6 Feb 2026.